Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-8-4
|
pubmed:abstractText |
Research on the sigma receptor, a binding site associated with drug-induced psychotomimetic behaviors, has been hampered because most sigma agonists also interact with the phencyclidine (PCP) receptor. (+)-Pentazocine, a human psychotogen, is a selective sigma receptor ligand. To demonstrate sigma receptor activities, we studied the behavioral and electrophysiologic actions for (+)-pentazocine. In the behavioral drug discrimination procedure in which rats were trained to discriminate between 2.0 mg/kg (5.59 mumol/kg) (+)-pentazocine and saline, (+)-pentazocine produced dose-related increases in the percentage of trials completed on the (+)-pentazocine lever. At a dose of 1.0 mg/kg (3.29 mumol/kg) (+)-N-allylnormetazocine generalized completely to (+)-pentazocine. By contrast, PCP only partially generalized. In the visual evoked potential test, these compounds produced a significant dose-dependent slowing of the N2 latency. This response was prevented by haloperidol pretreatment. These results demonstrate pharmacologic actions for the selective sigma receptor ligand (+)-pentazocine and suggest some overlapping pharmacologic properties of the sigma and PCP receptor sites despite differences in central nervous system distribution.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Pentazocine,
http://linkedlifedata.com/resource/pubmed/chemical/Phenazocine,
http://linkedlifedata.com/resource/pubmed/chemical/Phencyclidine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurotransmitter,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Phencyclidine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, sigma,
http://linkedlifedata.com/resource/pubmed/chemical/SK&F 10047
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0893-133X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-7
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:2855202-Animals,
pubmed-meshheading:2855202-Avoidance Learning,
pubmed-meshheading:2855202-Brain,
pubmed-meshheading:2855202-Discrimination Learning,
pubmed-meshheading:2855202-Evoked Potentials, Visual,
pubmed-meshheading:2855202-Male,
pubmed-meshheading:2855202-Membranes,
pubmed-meshheading:2855202-Pentazocine,
pubmed-meshheading:2855202-Phenazocine,
pubmed-meshheading:2855202-Phencyclidine,
pubmed-meshheading:2855202-Rabbits,
pubmed-meshheading:2855202-Rats,
pubmed-meshheading:2855202-Rats, Inbred F344,
pubmed-meshheading:2855202-Receptors, Neurotransmitter,
pubmed-meshheading:2855202-Receptors, Opioid,
pubmed-meshheading:2855202-Receptors, Phencyclidine,
pubmed-meshheading:2855202-Receptors, sigma,
pubmed-meshheading:2855202-Reference Values
|
pubmed:year |
1988
|
pubmed:articleTitle |
Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
|
pubmed:affiliation |
E.I. du Pont de Nemours & Co., Inc., Medical Products Department, Wilmington, Delaware 19898.
|
pubmed:publicationType |
Journal Article
|